The current standing of autologous haematopoietic stem cell transplantation for the treatment of multiple sclerosis

Autologous haematopoietic stem cell transplantation (aHSCT) is gaining traction as a valuable treatment option for patients affected by severe multiple sclerosis (MS), particularly the relapsing–remitting form. We describe the current literature in terms of clinical trials, observational and retrosp...

Descripción completa

Detalles Bibliográficos
Autores principales: Willison, A. G., Ruck, T., Lenz, G., Hartung, H. P., Meuth, S. G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2022
Materias:
Neurological Update
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8995166/
https://www.ncbi.nlm.nih.gov/pubmed/35399125
http://dx.doi.org/10.1007/s00415-022-11063-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8995166/
https://www.ncbi.nlm.nih.gov/pubmed/35399125
http://dx.doi.org/10.1007/s00415-022-11063-5

Ejemplares similares